These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24707051)

  • 1. Exploiting polypharmacology for drug target deconvolution.
    Gujral TS; Peshkin L; Kirschner MW
    Proc Natl Acad Sci U S A; 2014 Apr; 111(13):5048-53. PubMed ID: 24707051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploiting polypharmacology to dissect host kinases and kinase inhibitors that modulate endothelial barrier integrity.
    Dankwa S; Dols MM; Wei L; Glennon EKK; Kain HS; Kaushansky A; Smith JD
    Cell Chem Biol; 2021 Dec; 28(12):1679-1692.e4. PubMed ID: 34216546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent Polypharmacology-Driven Cellular Activity of Structurally Similar Multi-Kinase Inhibitors through Cumulative Effects on Individual Targets.
    Sumi NJ; Ctortecka C; Hu Q; Bryant AT; Fang B; Remsing Rix LL; Ayaz M; Kinose F; Welsh EA; Eschrich SA; Lawrence HR; Koomen JM; Haura EB; Rix U
    Cell Chem Biol; 2019 Sep; 26(9):1240-1252.e11. PubMed ID: 31257184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational Polypharmacology: Systematically Identifying and Engaging Multiple Drug Targets To Promote Axon Growth.
    Al-Ali H; Lee DH; Danzi MC; Nassif H; Gautam P; Wennerberg K; Zuercher B; Drewry DH; Lee JK; Lemmon VP; Bixby JL
    ACS Chem Biol; 2015 Aug; 10(8):1939-51. PubMed ID: 26056718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel application of the published kinase inhibitor set to identify therapeutic targets and pathways in triple negative breast cancer subtypes.
    Matossian MD; Elliott S; Hoang VT; Burks HE; Phamduy TB; Chrisey DB; Zuercher WJ; Drewry DH; Wells C; Collins-Burow B; Burow ME
    PLoS One; 2017; 12(8):e0177802. PubMed ID: 28771473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
    Gao Y; Davies SP; Augustin M; Woodward A; Patel UA; Kovelman R; Harvey KJ
    Biochem J; 2013 Apr; 451(2):313-28. PubMed ID: 23398362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploiting polypharmacology for improving therapeutic outcome of kinase inhibitors (KIs): An update of recent medicinal chemistry efforts.
    Ma X; Lv X; Zhang J
    Eur J Med Chem; 2018 Jan; 143():449-463. PubMed ID: 29202407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polypharmacology in Drug Discovery: A Review from Systems Pharmacology Perspective.
    Zhang W; Bai Y; Wang Y; Xiao W
    Curr Pharm Des; 2016; 22(21):3171-81. PubMed ID: 26907941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel multi-modal drug repurposing approach for identification of potent ACK1 inhibitors.
    Phatak SS; Zhang S
    Pac Symp Biocomput; 2013; ():29-40. PubMed ID: 23424109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harnessing systematic protein-ligand interaction fingerprints for drug discovery.
    Zhao Z; Bourne PE
    Drug Discov Today; 2022 Oct; 27(10):103319. PubMed ID: 35850431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Data structures for computational compound promiscuity analysis and exemplary applications to inhibitors of the human kinome.
    Miljković F; Bajorath J
    J Comput Aided Mol Des; 2020 Jan; 34(1):1-10. PubMed ID: 31792884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polypharmacology-based ceritinib repurposing using integrated functional proteomics.
    Kuenzi BM; Remsing Rix LL; Stewart PA; Fang B; Kinose F; Bryant AT; Boyle TA; Koomen JM; Haura EB; Rix U
    Nat Chem Biol; 2017 Dec; 13(12):1222-1231. PubMed ID: 28991240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Label-Free Cell Phenotypic Assays for Assessing Drug Polypharmacology.
    Wang J; Zhang X; Fang Y; Liang X
    Curr Pharm Des; 2016; 22(21):3190-200. PubMed ID: 26907946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deep Learning Enhancing Kinome-Wide Polypharmacology Profiling: Model Construction and Experiment Validation.
    Li X; Li Z; Wu X; Xiong Z; Yang T; Fu Z; Liu X; Tan X; Zhong F; Wan X; Wang D; Ding X; Yang R; Hou H; Li C; Liu H; Chen K; Jiang H; Zheng M
    J Med Chem; 2020 Aug; 63(16):8723-8737. PubMed ID: 31364850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-Based Kinase Profiling To Understand the Polypharmacological Behavior of Therapeutic Molecules.
    Dutta D; Das R; Mandal C; Mandal C
    J Chem Inf Model; 2018 Jan; 58(1):68-89. PubMed ID: 29243930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polypharmacology in Precision Oncology: Current Applications and Future Prospects.
    Antolin AA; Workman P; Mestres J; Al-Lazikani B
    Curr Pharm Des; 2016; 22(46):6935-6945. PubMed ID: 27669965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-Targeting Bioactive Compounds Extracted from Essential Oils as Kinase Inhibitors.
    Maruca A; Lanzillotta D; Rocca R; Lupia A; Costa G; Catalano R; Moraca F; Gaudio E; Ortuso F; Artese A; Trapasso F; Alcaro S
    Molecules; 2020 May; 25(9):. PubMed ID: 32384767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragment-Based Discovery of a Dual pan-RET/VEGFR2 Kinase Inhibitor Optimized for Single-Agent Polypharmacology.
    Frett B; Carlomagno F; Moccia ML; Brescia A; Federico G; De Falco V; Admire B; Chen Z; Qi W; Santoro M; Li HY
    Angew Chem Int Ed Engl; 2015 Jul; 54(30):8717-21. PubMed ID: 26126987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery.
    Ravikumar B; Aittokallio T
    Expert Opin Drug Discov; 2018 Feb; 13(2):179-192. PubMed ID: 29233023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated Analysis of Drug Sensitivity and Selectivity to Predict Synergistic Drug Combinations and Target Coaddictions in Cancer.
    Jaiswal A; Yadav B; Wennerberg K; Aittokallio T
    Methods Mol Biol; 2019; 1888():205-217. PubMed ID: 30519949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.